Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of ...
A conversation with Caroline Montojo, president and CEO of the Dana Foundation, a philanthropic organization that explores the connections between neuroscience and society's challenges and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results